Supplementary MaterialsSupplementary materials. (very late antigen-4) targeted liposomes was compared in myeloma and supporting cells, as well as the effectivity of free and liposome-encapsulated chemotherapy (bortezomib, doxorubicin). Either cocultured myeloma cell lines or primary CD138+ myeloma cells received the treatments. Outcomes Liposomes (~75C110 nm) passively diffused through SKQ1 Bromide inhibitor the entire heterogeneously porous (~80C850… Continue reading Supplementary MaterialsSupplementary materials. (very late antigen-4) targeted liposomes was compared in